A102V (p.Ala102Val) variant of TNXB (Tenascin-X)
A102V (p.Ala102Val) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.68 / 1. The record also includes structural context.
A102V (p.Ala102Val) variant details
- p.Ala102Val
- NCI-TCGA Cosmic COSV6447
- cosmic curated COSV64478
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.683
- ESM-1b 1.00
- AlphaMissense 0.30
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available